CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Boston Scientific Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Boston Scientific Corporation
300 Boston Scientific Way
Phone: (508) 683-4000p:508 683-4000 MARLBOROUGH, MA  01752-1291  United States Ticker: BSXBSX
Business Summary
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. It also owns the transcarotid artery revascularization (TCAR) platform.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYesYes-

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes-YesYes

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
3845 Electromedical and electrotherapeutic apparatus
5047 Medical, dental, and hospital equipment and supplies
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer Michael F.Mahoney 59 5/1/2016 10/17/2011
Chief Financial Officer, Executive Vice President Daniel J.Brennan 58 1/1/2014 1/1/2014
Executive Vice President - Human Resources WendyCarruthers 55 2/1/2022 12/1/2012
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
BTG INTERNATIONAL (HOLDINGS) LIMITED 100 NEW BRIDGE STREET LONDON UK
BTG INTERNATIONAL LIMITED 100 NEW BRIDGE STREET LONDON UK
BTG MANAGEMENT SERVICES LIMITED 100 NEW BRIDGE STREET LONDON UK
62 additional Subsidiary records available in full report.

Business Names
Business Name
34 Biomedical Merger Corp.
9357-1867 Quebec Inc.
Acotec Scientific Holdings Limited
197 additional Business Names available in full report.

General Information
Number of Employees: 48,000 (As of 12/31/2023)
Outstanding Shares: 1,473,827,485 (As of 10/29/2024)
Shareholders: 5,432
Stock Exchange: NYSE
Federal Tax Id: 042695240
Fax Number: (508) 650-8923


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024